JPH04305592A - Saccharide cinnamic acid derivative and ultraviolet light absorber - Google Patents
Saccharide cinnamic acid derivative and ultraviolet light absorberInfo
- Publication number
- JPH04305592A JPH04305592A JP41655090A JP41655090A JPH04305592A JP H04305592 A JPH04305592 A JP H04305592A JP 41655090 A JP41655090 A JP 41655090A JP 41655090 A JP41655090 A JP 41655090A JP H04305592 A JPH04305592 A JP H04305592A
- Authority
- JP
- Japan
- Prior art keywords
- saccharide
- cinnamic acid
- sugar
- acid derivative
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Saccharide cinnamic acid derivative Chemical class 0.000 title abstract description 31
- 239000006097 ultraviolet radiation absorber Substances 0.000 title abstract description 4
- 229940124543 ultraviolet light absorber Drugs 0.000 title abstract 2
- 239000000126 substance Substances 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 3
- 235000000346 sugar Nutrition 0.000 claims description 30
- 239000006096 absorbing agent Substances 0.000 claims description 16
- 150000001851 cinnamic acid derivatives Chemical class 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 29
- 239000000845 maltitol Substances 0.000 abstract description 16
- 235000010449 maltitol Nutrition 0.000 abstract description 16
- 229940035436 maltitol Drugs 0.000 abstract description 16
- 238000010521 absorption reaction Methods 0.000 abstract description 13
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 abstract description 12
- 239000002904 solvent Substances 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 150000002148 esters Chemical class 0.000 abstract description 5
- 239000003054 catalyst Substances 0.000 abstract description 4
- 238000003756 stirring Methods 0.000 abstract description 4
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 238000005809 transesterification reaction Methods 0.000 abstract description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 4
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 16
- 239000008213 purified water Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 13
- 239000012071 phase Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 11
- 239000000600 sorbitol Substances 0.000 description 11
- 235000010356 sorbitol Nutrition 0.000 description 11
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 238000000862 absorption spectrum Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- ZYDQSPYFLQSONW-UHFFFAOYSA-N 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoic acid Chemical compound COC(C(O)=O)=C(OC)C1=CC=CC=C1OC ZYDQSPYFLQSONW-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical group C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 235000013985 cinnamic acid Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003839 salts Chemical group 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229930016911 cinnamic acid Natural products 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000003973 paint Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229940067596 butylparaben Drugs 0.000 description 3
- 229940114081 cinnamate Drugs 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- GEBJVWNZJDEYAX-UHFFFAOYSA-N methyl 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoate Chemical compound COC(=O)C(OC)=C(OC)C1=CC=CC=C1OC GEBJVWNZJDEYAX-UHFFFAOYSA-N 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229960005066 trisodium edetate Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KYWXRBNOYGGPIZ-UHFFFAOYSA-N 1-morpholin-4-ylethanone Chemical compound CC(=O)N1CCOCC1 KYWXRBNOYGGPIZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- KAJJUFUPJGVIFJ-UHFFFAOYSA-N 3-methylpyrrolidine-2,5-dione Chemical compound CC1CC(=O)NC1=O KAJJUFUPJGVIFJ-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N R-12-HOA Natural products CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FXEDRSGUZBCDMO-PHEQNACWSA-N [(e)-3-phenylprop-2-enoyl] (e)-3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1/C=C/C(=O)OC(=O)\C=C\C1=CC=CC=C1 FXEDRSGUZBCDMO-PHEQNACWSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- FXEDRSGUZBCDMO-UHFFFAOYSA-N cinnamic acid anhydride Natural products C=1C=CC=CC=1C=CC(=O)OC(=O)C=CC1=CC=CC=C1 FXEDRSGUZBCDMO-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- AASUFOVSZUIILF-UHFFFAOYSA-N diphenylmethanone;sodium Chemical compound [Na].C=1C=CC=CC=1C(=O)C1=CC=CC=C1 AASUFOVSZUIILF-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002951 idosyl group Chemical class C1([C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- QIGJYVCQYDKYDW-NSYYTRPSSA-N nigerose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-NSYYTRPSSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical class OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は糖桂皮酸誘導体及び紫外
線吸収剤、特に紫外線吸収性を有する水溶性の糖桂皮酸
誘導体及びそれを用いた紫外線吸収剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to sugar cinnamic acid derivatives and ultraviolet absorbers, and more particularly to water-soluble sugar cinnamic acid derivatives having ultraviolet absorbing properties and ultraviolet absorbers using the same.
【0002】0002
【従来の技術】太陽光線に含まれる紫外線は、400n
m〜320nmの長波長紫外線(UV−A)、320n
m〜280nmの中波長紫外線(UV−B)、280n
m以下の短波長紫外線(UV−C)に分類される。この
うち、290nm以下の波長の紫外線は、オゾン層によ
って吸収され、地表に到達しない。[Prior Art] The ultraviolet rays contained in sunlight are 400n
m~320nm long wavelength ultraviolet (UV-A), 320n
Medium wavelength ultraviolet light (UV-B) from m to 280nm, 280n
It is classified as short wavelength ultraviolet light (UV-C) with wavelengths below m. Among these, ultraviolet rays with a wavelength of 290 nm or less are absorbed by the ozone layer and do not reach the earth's surface.
【0003】地表に届く紫外線は化学反応を強く誘発す
るところから、各種塗料、コーティング剤等に紫外線吸
収剤の配合が試行されている。一方、紫外線は人間の皮
膚に様々な影響を及ぼす。UV−Aによっても一次黒化
の惹起等が問題となるが、特にUV−Bの影響は甚大で
、一定量以上の光量が皮膚に照射されると、紅班や水泡
を形成したり、メラニン形成が亢進され色素沈着を生じ
る等の問題を引起こし、さらに長期的には皮膚老化を促
進し、皮膚癌等の原因となる。Since ultraviolet rays that reach the earth's surface strongly induce chemical reactions, attempts have been made to incorporate ultraviolet absorbers into various paints, coatings, and the like. On the other hand, ultraviolet rays have various effects on human skin. Although UV-A causes problems such as primary darkening, the effects of UV-B are particularly severe. Accelerated formation causes problems such as pigmentation, and in the long term it accelerates skin aging and causes skin cancer.
【0004】そこで従来より紫外線の影響を除去するた
め、各種紫外線吸収剤が開発されてきた。既存の紫外線
吸収剤としては、PABA誘導体、桂皮酸誘導体、サリ
チル酸誘導体、ベンゾフェノン誘導体、ウロカニン酸誘
導体、カンファー誘導体、複素環誘導体等が知られてい
る。[0004] Various types of ultraviolet absorbers have been developed to eliminate the effects of ultraviolet rays. As existing ultraviolet absorbers, PABA derivatives, cinnamic acid derivatives, salicylic acid derivatives, benzophenone derivatives, urocanic acid derivatives, camphor derivatives, heterocyclic derivatives, etc. are known.
【0005】そして、これらのUV−B吸収剤は、塗料
、コーティング剤あるいは化粧品、医薬品、医薬部外品
等の皮膚外用剤に配合されているが、例えば皮膚外用剤
の場合、その基剤には低分子量のジメチルシロキサン系
基剤が広く使用されている。すなわち、最も頻繁に日焼
け止を使用するのが夏であるため、耐汗性、耐水性等の
観点から紫外線吸収剤として使用されてきたものは、油
溶性のものが殆どであった。[0005] These UV-B absorbers are incorporated into paints, coatings, cosmetics, pharmaceuticals, quasi-drugs, and other external skin preparations. For example, in the case of external skin preparations, they are A low molecular weight dimethylsiloxane base is widely used. That is, since sunscreens are most frequently used in summer, most of the UV absorbers that have been used from the viewpoint of sweat resistance, water resistance, etc. have been oil-soluble.
【0006】[0006]
【発明が解決しようとする課題】ところが、最近では日
常の生活で受ける紫外線の影響についても問題になって
おり、通常のスキンケアでも日焼け止が望まれている。
このため、■化粧水等の水系のスキンケア製品にも多量
に配合できること、■より高い紫外線吸収効果を有する
外用剤を処方する上でも系全体に多量の紫外線吸収剤を
配合できる方が良いので、油相だけではなく、水相にも
紫外線吸収剤を配合することが望まれること、等の観点
から水溶性紫外線吸収剤の開発が強く要望されていた。[Problems to be Solved by the Invention] However, in recent years, the influence of ultraviolet rays in daily life has become a problem, and sunscreens are desired for normal skin care. For this reason, ■It is better to be able to incorporate large amounts of UV absorbers into water-based skin care products such as lotions, and ■When formulating external preparations with higher UV absorption effects, it is better to be able to incorporate large amounts of UV absorbers into the entire system. There has been a strong demand for the development of water-soluble ultraviolet absorbers from the viewpoint of the desire to incorporate ultraviolet absorbers not only in the oil phase but also in the aqueous phase.
【0007】しかし、従来のUV−B吸収剤は、前述し
たようにその殆どが油溶性で水溶性が低く、処方が制限
されていた。水溶性UV−B吸収剤としては、僅かに2
−ヒドロキシ−4−メトキシ−5−スルフォキソニウム
ベンゾフェノンナトリウム塩が知られているのみであり
、しかもこれは塩であるので処方系のpHに影響をもた
らすという課題があった。However, as mentioned above, most conventional UV-B absorbers are oil-soluble and have low water solubility, which limits their formulation. As a water-soluble UV-B absorber, only 2
-Hydroxy-4-methoxy-5-sulfoxonium benzophenone sodium salt is only known, and since it is a salt, there is a problem that it affects the pH of the formulation system.
【0008】本発明は前記従来技術の課題に鑑みなされ
たものであり、その目的は、優れたUV−B吸収性を有
し、しかも水溶性である糖桂皮酸誘導体及び紫外線吸収
剤を提供することにある。The present invention has been made in view of the problems of the prior art, and its purpose is to provide a sugar cinnamic acid derivative and an ultraviolet absorber that have excellent UV-B absorption properties and are water-soluble. There is a particular thing.
【0009】[0009]
【課題を解決するための手段】前記目的を達成するため
に本発明者らが鋭意検討した結果、桂皮酸に糖を結合さ
せた糖桂皮酸誘導体に優れたUV−B吸収性及び水溶性
があることを見出し、本発明を完成するに至った。[Means for Solving the Problems] In order to achieve the above object, the present inventors have made intensive studies and found that a sugar cinnamic acid derivative in which sugar is bonded to cinnamic acid has excellent UV-B absorption and water solubility. They discovered something and completed the present invention.
【0010】すなわち本出願の請求項1記載の糖桂皮酸
誘導体は、下記一般式化2で表わされることを特徴とす
る。That is, the sugar cinnamic acid derivative according to claim 1 of the present application is characterized by being represented by the following general formula 2.
【化2】
(式中Aは糖又は糖アルコールからn個の水酸基を除い
た残基、Xはアルコキシ基、aは1〜3の整数、nは整
数)[Chemical formula 2] (In the formula, A is a residue obtained by removing n hydroxyl groups from a sugar or sugar alcohol, X is an alkoxy group, a is an integer from 1 to 3, and n is an integer)
【0011】また、本出願の請求項2記載の紫外線吸収
剤は、上記一般式化2で表わされることを特徴とする。[0011] Furthermore, the ultraviolet absorbent according to claim 2 of the present application is characterized by being represented by the above general formula 2.
【0012】以下、本発明の構成をさらに詳細に説明す
る。一般式化2において、Aの糖の具体例としては、グ
ルコース、ガラクトース、キシロース、フルクトース、
アルトロース、タロース、マンノース、アラビノース、
イドース、リキソース、リボース、アロース等の単糖類
及びその混合物、又は、マルトース、イソマルソース、
ラクトース、キシロビオース、ケンチビオース、コージ
オビオース、セロビオース、ソホロース、ニゲロース、
スクロース、メリビオース、ラミナリビオース、ルチノ
ース等の二糖類及びその混合物、更にマルチトール、ソ
ルビトール、マンニトール、ガラクチトール、グルシト
ール、イノシトールなどの糖アルコール及びその混合物
が挙げられ、更にそれ以上の多糖を用いることもできる
。また、単糖類、二糖類、糖アルコール、及びそれ以上
の多糖の混合物でも構わない。The configuration of the present invention will be explained in more detail below. In general formula 2, specific examples of sugar A include glucose, galactose, xylose, fructose,
altrose, talose, mannose, arabinose,
Monosaccharides such as idose, lyxose, ribose, allose and mixtures thereof, or maltose, isomalsose,
Lactose, xylobiose, kenchibiose, cordiobiose, cellobiose, sophorose, nigerose,
Examples include disaccharides and mixtures thereof such as sucrose, melibiose, laminaribiose, and rutinose, and sugar alcohols and mixtures thereof such as maltitol, sorbitol, mannitol, galactitol, glucitol, and inositol. You can also do it. Further, a mixture of monosaccharides, disaccharides, sugar alcohols, and higher polysaccharides may be used.
【0013】Xとしては、例えばメトキシ基、エトキシ
基、イソプロピル基等が挙げられる。いずれも、水溶性
及びUV−B吸収波長に顕著な差はないが、工業性等か
ら、特にメトキシ基が好ましい。Examples of X include methoxy, ethoxy, and isopropyl groups. Although there is no significant difference in water solubility and UV-B absorption wavelength, a methoxy group is particularly preferred from the viewpoint of industrial efficiency.
【0014】本発明の糖桂皮酸誘導体は、エステル交換
反応(ホットメルト法、シュネル法、ネブラスカ−シュ
ネル法、ジマー法、ネブラスカ−DKS法、米国特許2
,999,858号(1961)、米国特許2,948
,717号(1960)、米国特許3,021,324
号(1962)、 ドイツ特許1,098,501号(
1961)、日本国特許404,285(1962)等
)、桂皮酸無水物との反応、桂皮酸クロリドとの反応等
、一般にエステル化に用いられる反応で合成することが
出来る。例えば、ネブラスカーシュネル法で合成するこ
とができる。The sugar cinnamic acid derivative of the present invention can be prepared by transesterification (hot melt method, Schnell method, Nebraska-Schnell method, Zimmer method, Nebraska-DKS method, US Pat.
, 999,858 (1961), U.S. Patent No. 2,948
, No. 717 (1960), U.S. Patent No. 3,021,324
No. (1962), German Patent No. 1,098,501 (
1961), Japanese Patent No. 404,285 (1962), etc.), reaction with cinnamic acid anhydride, reaction with cinnamic acid chloride, etc., and can be synthesized by reactions generally used for esterification. For example, it can be synthesized by the Nebraska-Schnell method.
【0015】即ち、糖をジメチルホルムアミド、ジメチ
ルスルホキシド、ジオキサン、ジメチルアセトアミド、
N−メチルピロリドン、N−アセチルモルホリン、N−
メチルコハク酸イミド等の非水系溶媒に溶かし、これに
一般式化3:That is, sugar can be converted into dimethylformamide, dimethylsulfoxide, dioxane, dimethylacetamide,
N-methylpyrrolidone, N-acetylmorpholine, N-
Dissolved in a non-aqueous solvent such as methylsuccinimide, and added to the general formula 3:
【化3】
(ただし、式中Rは、メチル基、エチル基等の低級アル
キル基であり、Xおよびaは、前記式化2に同じ)で示
される化合物を添加して、触媒の存在下、50〜130
℃で攪拌、エステル交換反応させることにより得られる
。この際、反応は減圧下で行ない、一般式化2で示され
る化合物は単独でも2種以上を併用してもよい。[Formula 3] (wherein R is a lower alkyl group such as a methyl group or ethyl group, and X and a are the same as in Formula 2 above) is added, and in the presence of a catalyst, , 50-130
It is obtained by stirring and transesterifying at °C. At this time, the reaction is carried out under reduced pressure, and the compounds represented by the general formula 2 may be used alone or in combination of two or more.
【0016】また、上記の触媒としては、硫酸等の鉱酸
、水酸化リチウム、水酸化ナトリウム、水酸化カリウム
、炭酸カリウム、炭酸ナトリウム等のアルカリ、ナトリ
ウムメチラート、ナトリウムエチラート等のナトリウム
アルコラート、N−メチルベンジルアミン等のアミン等
が挙げられる。The above catalysts include mineral acids such as sulfuric acid, alkalis such as lithium hydroxide, sodium hydroxide, potassium hydroxide, potassium carbonate and sodium carbonate, sodium alcoholates such as sodium methylate and sodium ethylate, Examples include amines such as N-methylbenzylamine.
【0017】この反応に使用される糖と一般式化3で示
される化合物のモル比は、例えばモノエステルを主生成
物として得ようとする場合1〜3:1で更に好ましくは
2〜3:1である。糖が多過ぎると、糖が多量に残って
後の精製に支障をきたす。The molar ratio of the sugar used in this reaction to the compound represented by the general formula 3 is, for example, 1 to 3:1, more preferably 2 to 3:1, when monoester is to be obtained as the main product. It is 1. If there is too much sugar, a large amount of sugar will remain and interfere with subsequent purification.
【0018】一般式化3で示される化合物がすべて消費
された場合、反応系の触媒を中和する目的で酢酸、塩酸
、硫酸、リン酸等の酸、水酸化リチウム、水酸化ナトリ
ウム、水酸化カリウム等のアルカリを加え、反応溶媒を
減圧留去する。When all the compounds represented by the general formula 3 are consumed, acids such as acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, lithium hydroxide, sodium hydroxide, hydroxide etc. are added for the purpose of neutralizing the catalyst in the reaction system. An alkali such as potassium is added, and the reaction solvent is distilled off under reduced pressure.
【0019】このようにして得られた反応生成物には、
一般式化2で示される糖桂皮酸誘導体のほか、中和時の
塩、糖等が共存している。そのため、例えば糖と塩を除
去する場合、メチルアルコール、エチルアルコール、ブ
チルアルコール、イソプロピルアルコール等の糖を溶解
しない溶媒で抽出したり、塩を多量に含む水とメチルエ
チルケトン、n−ブタノールで分配し、有機溶媒層を分
取することにより精製できる。The reaction product thus obtained includes:
In addition to the sugar cinnamic acid derivative represented by the general formula 2, salts, sugars, etc. during neutralization coexist. Therefore, for example, when removing sugar and salt, extraction is performed with a solvent that does not dissolve sugar, such as methyl alcohol, ethyl alcohol, butyl alcohol, or isopropyl alcohol, or partitioning with water containing a large amount of salt and methyl ethyl ketone or n-butanol. Purification can be achieved by separating the organic solvent layer.
【0020】また、糖と塩を除去し、結合したエステル
基の数によって化合物を分離する場合、反応生成物を水
または水とアルコールの混液に懸濁させ、ハイパーポー
ラスポリマー(例えば三菱化成工業株式会社製のハイポ
ーラス樹脂)、オクタデシルシリカなどの逆相分配カラ
ムで、始めに水で通液し、次にメタノール、エタノール
などのアルコールやアセトニトリルなどの極性有機溶媒
と水の混液で通液し、この液を分取することにより分離
・精製できる。その他、Snellらの方法、特公昭4
1−6852、特公昭40−26250等や、アセトン
で抽出し精製することもできる。In addition, when removing sugars and salts and separating compounds according to the number of bonded ester groups, the reaction product is suspended in water or a mixture of water and alcohol, and a hyperporous polymer (for example, Mitsubishi Chemical Corporation) First, water is passed through a reversed-phase distribution column such as octadecyl silica (high porous resin manufactured by the company), and then a mixture of water and an alcohol such as methanol or ethanol or a polar organic solvent such as acetonitrile is passed through the column. Separation and purification can be achieved by fractionating this liquid. Others include the method of Snell et al.
1-6852, Japanese Patent Publication No. 40-26250, etc., or extraction and purification with acetone.
【0021】前記のように合成した糖桂皮酸誘導体は、
抽出溶媒を留去したり、カラムにより精製した後用いて
もよく、そのまま用いてもよい。The sugar cinnamic acid derivative synthesized as described above is
It may be used after distilling off the extraction solvent or purifying with a column, or it may be used as it is.
【0022】このようにして得られる糖桂皮酸は固体で
、化学安定性、酸化安定性、安全性に優れ、水溶性で、
しかもUV−B領域に吸収を有する上、保湿性に優れる
という機能を持つ。The sugar cinnamic acid thus obtained is solid, has excellent chemical stability, oxidative stability, and safety, and is water-soluble.
In addition, it has absorption in the UV-B region and has excellent moisturizing properties.
【0023】上記の糖桂皮酸誘導体は、塗料やインク、
プラスチック、コーティング剤、化学繊維等の化学製品
などに配合できる他、医薬品、医薬部外品、化粧品及び
洗浄料の成分として配合され得る。また、本発明にかか
る糖桂皮酸誘導体に加えて通常用いられる他の塗料、コ
ーティング、化粧品や医薬品成分を適宜配合することが
できる。The above sugar cinnamic acid derivatives can be used in paints, inks,
It can be blended into chemical products such as plastics, coating agents, and chemical fibers, and can also be blended as an ingredient in pharmaceuticals, quasi-drugs, cosmetics, and cleaning products. In addition to the sugar cinnamic acid derivative according to the present invention, other commonly used paints, coatings, cosmetics, and pharmaceutical ingredients can be appropriately blended.
【0024】例えば、流動パラフィン、スクワラン、ワ
セリン、セチルアルコール、イソステアリルアルコール
、2−エチルヘキサン酸セチル、2−オクチルドデシル
アルコール、トリイソステアリン酸グリセリン、マカデ
ミアンナッツ油、ラノリン等の各種炭化水素、油脂類、
ロウ類等の油性成分、シリコーン類、界面活性剤、増粘
剤、中和剤、防腐剤、殺菌剤、酸化防止剤、粉体成分、
色素、香料、他の紫外線吸収剤、薬効剤、金属封鎖剤、
pH調整剤等が挙げられる。For example, various hydrocarbons and fats and oils such as liquid paraffin, squalane, petrolatum, cetyl alcohol, isostearyl alcohol, cetyl 2-ethylhexanoate, 2-octyldodecyl alcohol, glyceryl triisostearate, macadamian nut oil, and lanolin. kind,
Oily components such as waxes, silicones, surfactants, thickeners, neutralizing agents, preservatives, bactericidal agents, antioxidants, powder components,
Pigments, fragrances, other UV absorbers, medicinal agents, sequestering agents,
Examples include pH adjusters.
【0025】[0025]
【発明の効果】本発明にかかる糖桂皮酸誘導体及び紫外
線吸収剤は、化学的安定性及び水溶性に優れ、しかもU
V−B領域の紫外線を効率的に吸収することができる。Effects of the Invention The sugar cinnamic acid derivative and ultraviolet absorber according to the present invention have excellent chemical stability and water solubility, and
Ultraviolet rays in the V-B region can be efficiently absorbed.
【0026】[0026]
【実施例】次に、試験例及び実施例によって本発明をさ
らに詳細に説明する。なお、本発明は、これによって限
定されるものではない。まず、本発明にかかる糖桂皮酸
の製造方法について説明する。[Examples] Next, the present invention will be explained in more detail with reference to test examples and examples. Note that the present invention is not limited to this. First, the method for producing sugar cinnamic acid according to the present invention will be explained.
【0027】実施例1(マルチトールトリメトキシン桂
皮酸エステル)トリメトキシ桂皮酸15gを、HCl−
MeOH溶液150mlに溶解し、加熱還流を1時間し
た後、減圧濃縮した。酢酸エチル300mlで抽出し、
精製水200mlで5回洗浄した後、有機層を無水硫酸
マグネシウムで乾燥し、結晶を濾去した後、減圧濃縮し
た。得られた生成物をメタノールで再結晶し、再結晶収
率97%にてトリメトキシ桂皮酸メチルエステル15.
5gを得た。Example 1 (Maltitol trimethoxine cinnamic acid ester) 15 g of trimethoxycinnamic acid was dissolved in HCl-
The solution was dissolved in 150 ml of MeOH solution, heated under reflux for 1 hour, and then concentrated under reduced pressure. Extract with 300ml of ethyl acetate,
After washing 5 times with 200 ml of purified water, the organic layer was dried over anhydrous magnesium sulfate, the crystals were filtered off, and then concentrated under reduced pressure. The obtained product was recrystallized from methanol to give trimethoxycinnamic acid methyl ester with a recrystallization yield of 97%.
5g was obtained.
【0028】マルチトール1.28gを、予め乾燥して
おいたジメチルスルホキシド5mlに溶解し、合成した
トリメトシキ桂皮酸メチルエステル3gを加え、続いて
攪拌下、炭酸カリウム1.6g加えた後、減圧下100
℃にて2時間加熱攪拌した。反応系を室温まで空冷した
後、塩酸で中和した。[0028] 1.28 g of maltitol was dissolved in 5 ml of dimethyl sulfoxide that had been dried in advance, and 3 g of the synthesized trimethoxycinnamic acid methyl ester was added thereto. Then, 1.6 g of potassium carbonate was added under stirring, and then the mixture was dissolved under reduced pressure. 100
The mixture was heated and stirred at ℃ for 2 hours. After air-cooling the reaction system to room temperature, it was neutralized with hydrochloric acid.
【0029】反応溶媒を減圧蒸留にて留去し、残留物を
ハイパーポーラスポリマー(三菱化成工業株式会社製の
ハイポーラス樹脂)のカラムクロマトグラフ法で展開溶
媒として初め精製水、次にエチルアルコール:精製水=
7:3を用いて分画すると、精製水の溶出部に塩化カリ
ウム、マルチトール及びジメチルスルホキシドが認めら
れ、エチルアルコール:精製水7:3溶出部を濃縮した
。The reaction solvent was distilled off under reduced pressure, and the residue was subjected to column chromatography using hyperporous polymer (high porous resin manufactured by Mitsubishi Chemical Industries, Ltd.) using first purified water and then ethyl alcohol as the developing solvent. Purified water =
When fractionation was performed using a 7:3 ratio, potassium chloride, maltitol, and dimethyl sulfoxide were found in the purified water eluate, and the ethyl alcohol:purified water 7:3 eluate was concentrated.
【0030】マルチトールモノトリメトキシ桂皮酸エス
テルの収量は2.01g(収率30.0%)であった。
また、得られたマルチトールトリメトキシ桂皮酸エ
ステルは、下記の(1)〜(4)の方法により分析した
。
このようにして得たマルチトールモノトリメトキシ桂皮
酸エステルを試料1とした。The yield of maltitol monotrimethoxycinnamate ester was 2.01 g (yield 30.0%). Moreover, the obtained maltitol trimethoxy cinnamic acid ester was analyzed by the following methods (1) to (4). The thus obtained maltitol monotrimethoxycinnamic acid ester was designated as Sample 1.
【0031】(1)赤外吸収スペクトル測定法日本分光
工業株式会社製、IRA−1赤外吸収スペクトル測定装
置を用い、neat法で測定したところ、3400cm
−1に水酸基の伸縮振動、2900cm−1付近にメト
キシ基の伸縮運動、 1690cm−1にカルボニル基
の伸縮運動による吸収が観測された。結果を図1に示す
。(1) Infrared absorption spectrum measurement method Using an IRA-1 infrared absorption spectrum measurement device manufactured by JASCO Corporation, measurement was performed using the neat method, and the result was 3400 cm.
Absorption due to the stretching vibration of the hydroxyl group at −1, the stretching motion of the methoxy group at around 2900 cm −1 , and the stretching motion of the carbonyl group at 1690 cm −1 was observed. The results are shown in Figure 1.
【0032】(2)13C−NMR測定法日本電子株式
会社製のJOEL GX−400により、CD3OD
を溶媒として、室温にて測定したところ、169〜10
2ppmにトリメトキシ桂皮酸部分に由来するシグナル
が、また62〜100ppmにマルチトール部分の炭素
に由来するシグナルがそれぞれ観測された。
結果を図2に示す。(2) 13C-NMR measurement method CD3OD was measured using JOEL GX-400 manufactured by JEOL Ltd.
When measured at room temperature using as a solvent, it was 169-10
A signal originating from the trimethoxycinnamic acid moiety was observed at 2 ppm, and a signal originating from the carbon of the maltitol moiety was observed at 62 to 100 ppm. The results are shown in Figure 2.
【0033】(3)1H−NMR測定法日本電子株式会
社製のJOEL GX−400により、CD3ODを
溶媒として、室温にて測定したところ、7.7〜6.4
ppmにトリメトキシ桂皮酸部分に由来するシグナルが
、また3.0〜5.0ppmにマルチトール部分の水素
に由来するシグナルがそれぞれ観測された。結果を図3
に示す。(3) 1H-NMR measurement method When measured at room temperature using CD3OD as a solvent using JOEL GX-400 manufactured by JEOL Ltd., the result was 7.7 to 6.4.
A signal originating from the trimethoxycinnamic acid moiety was observed at ppm, and a signal originating from the hydrogen of the maltitol moiety was observed at 3.0 to 5.0 ppm. The results are shown in Figure 3.
Shown below.
【0034】(4)紫外線吸収スペクトル測定法日本分
光工業株式会社製、UVIDEC 61OC紫外吸収ス
ペクトル測定装置を用い、溶媒メタノールで測定したと
ころ、230nm付近及び310nmに、極大吸収を示
した。結果を図4に示す。(4) Ultraviolet Absorption Spectrum Measuring Method When measured using a UVIDEC 61OC ultraviolet absorption spectrometer manufactured by JASCO Corporation and using methanol as a solvent, maximum absorption was observed at around 230 nm and at 310 nm. The results are shown in Figure 4.
【0035】実施例2(ソルヒ゛トールトリメトキシ桂
皮酸エステル)ソルビトール6.49gを予め乾燥して
おいたジメチルスルフォキシド26mlに溶解し、合成
したトリメトキシ桂皮酸メチルエルテル3.0gを加え
、続いて攪拌下に炭酸カリウム1.64gを加え、減圧
下2時間加熱攪拌した。反応後、室温まで空冷し塩酸で
中和した。Example 2 (Sorbitol trimethoxycinnamate ester) 6.49 g of sorbitol was dissolved in 26 ml of previously dried dimethyl sulfoxide, and 3.0 g of the synthesized methyl ester trimethoxycinnamate was added, followed by stirring. 1.64 g of potassium carbonate was added to the bottom, and the mixture was heated and stirred under reduced pressure for 2 hours. After the reaction, the mixture was air cooled to room temperature and neutralized with hydrochloric acid.
【0036】その後、溶媒を減圧留去し、得られた残留
物をハイパーポーラスポリマー(三菱化成工業株式会社
製のハイポーラス樹脂)のカラムクトマトグラフ法で展
開溶媒として初めに精製水、次にエチルアルコール:精
製水=1:1を用いて分画すると、精製水の溶出部に塩
化カリウム、ソルビトール及びジメチルスルホキシドが
認められ、エチルアルコール:精製水=1:1溶出部を
濃縮した。[0036] Thereafter, the solvent was distilled off under reduced pressure, and the resulting residue was subjected to a column chromatograph method using hyperporous polymer (high porous resin manufactured by Mitsubishi Chemical Industries, Ltd.) using first purified water and then purified water as a developing solvent. When fractionation was performed using ethyl alcohol:purified water=1:1, potassium chloride, sorbitol, and dimethyl sulfoxide were found in the eluate of purified water, and the eluate of ethyl alcohol:purified water=1:1 was concentrated.
【0037】ソルビトールモノトリメトキシ桂皮酸エス
テルの収量は8.6g(収率30.47%)であった。
このようにして得たソルビトールモノトリメトキシ桂皮
酸エステルは、(1)〜(4)の方法にて分析した。The yield of sorbitol monotrimethoxycinnamate ester was 8.6 g (yield 30.47%). The sorbitol monotrimethoxycinnamate ester thus obtained was analyzed by methods (1) to (4).
【0038】(1)赤外吸収スペクトル測定法日本分光
工業株式会社製、IRA−1赤外吸収スペクトル測定装
置を用い、neat法で測定したところ、3400cm
−1に水酸基の伸縮振動、2900cm−1付近にメト
キシ基の伸縮運動、1690cm−1にカルボニル基の
伸縮運動による吸収が観測された。結果を図5に示す。(1) Infrared absorption spectrum measurement method Using an IRA-1 infrared absorption spectrum measurement device manufactured by JASCO Corporation, measurement was performed using the neat method, and the result was 3400 cm.
Absorption due to the stretching vibration of the hydroxyl group at −1, the stretching motion of the methoxy group at around 2900 cm −1 , and the stretching motion of the carbonyl group at 1690 cm −1 was observed. The results are shown in Figure 5.
【0039】(2)13C−NMR測定法日本電子株式
会社製のJOEL GX−400により、CD3OD
を溶媒として、室温にて測定したところ、169〜10
6ppmにトリメトキシ桂皮酸部分に由来するシグナル
が、また62〜100ppmにマルチトール部分の炭素
に由来するシグナルがそれぞれ観測された。
結果を、図6に示す。(2) 13C-NMR measurement method CD3OD was measured using JOEL GX-400 manufactured by JEOL Ltd.
When measured at room temperature using as a solvent, it was 169-10
A signal originating from the trimethoxycinnamic acid moiety was observed at 6 ppm, and a signal originating from the carbon of the maltitol moiety was observed at 62 to 100 ppm. The results are shown in FIG.
【0040】(3)1H−NMR測定法日本電子株式会
社製のJOEL GX−400により、CD3ODを
溶媒として室温にて測定したところ、7.7〜6.4p
pmにトリメトキシ桂皮酸部分に由来するシグナルが、
また3.0〜5.0ppmにマルチトール部分の水素に
由来するシグナルがそれぞれ観測された。
結果を図7に示す。(3) 1H-NMR measurement method When measured at room temperature using CD3OD as a solvent using JOEL GX-400 manufactured by JEOL Ltd., 7.7 to 6.4p was measured.
The signal derived from the trimethoxycinnamic acid moiety in pm is
Further, signals derived from hydrogen in the maltitol moiety were observed at 3.0 to 5.0 ppm. The results are shown in FIG.
【0041】(4)紫外線吸収スペクトル測定法日本分
光工業株式会社製、UVIDEC 61OC紫外吸収ス
ペクトル測定装置を用い、溶媒メタノールで測定したと
ころ、230nm付近及び310nm付近に、極大吸収
を示した。結果を図8に示す。(4) Ultraviolet Absorption Spectrum Measuring Method When measured using a UVIDEC 61OC ultraviolet absorption spectrometer manufactured by JASCO Corporation and using methanol as a solvent, maximum absorption was observed at around 230 nm and around 310 nm. The results are shown in FIG.
【0042】なお、前記実施例1ないし実施例2にかか
る糖桂皮酸はいずれも水に対する溶解度は20重量%以
上であった。The solubility of the sugar cinnamic acids in Examples 1 and 2 in water was 20% by weight or more.
【0043】また、実施例1及び2で得られた化合物は
、白色固体であった。吸湿度が高く、融点の測定はでき
なかった。Furthermore, the compounds obtained in Examples 1 and 2 were white solids. Due to high moisture absorption, it was not possible to measure the melting point.
【0044】次に、以上のようにして得られた糖桂皮酸
誘導体を配合した皮膚外用剤について説明する。まず、
本発明にかかる皮膚外用剤の日焼け止効果について試験
を行った。Next, a skin preparation for external use containing the glycocinnamic acid derivative obtained as described above will be explained. first,
A test was conducted on the sunscreen effect of the skin external preparation according to the present invention.
【0045】試験例
下記の表1に示す処方において、糖桂皮酸誘導体を配合
した美容液と、対照例として2−ヒドキシ−4−メトキ
シ−5−スルフォキソニウムベンゾフェノンを配合した
美容液の製造を行った。Test Example Production of a serum containing a sugar cinnamic acid derivative and, as a control, a serum containing 2-hydroxy-4-methoxy-5-sulfoxonium benzophenone in the formulation shown in Table 1 below. I did it.
【0046】[0046]
【表1】
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−− 成 分
配合例
1 対照例1−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−A.(アルコール相)
エタノール
5.0% 5.0
%POEオレイルアルコールエーテル 2.
0 2.0香料
0.05 0.05B.(水相
)
1,3−ブチレングリコール
5.0 5.0マルチトールト
リメトキシ桂皮酸エステル
7.0 −2−ヒト
゛ロキシ−4−メトキシ−5−スルフォキソニウムヘ゛
ンソ゛フェノン −
7.0トリエタノールアミン
0.1 0.1
カルボキシビニルポリマー
0.15 0.15精製水
残 余 残 余−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−[Table 1] −−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−− Ingredients
Formulation example 1 Control example 1
−−−−−−−−−−−−−−−−−−−−−−−−−
--A. (Alcohol phase) Ethanol
5.0% 5.0
%POE oleyl alcohol ether 2.
0 2.0 fragrance
0.05 0.05B. (Aqueous phase) 1,3-butylene glycol
5.0 5.0 Maltitol trimethoxy cinnamic acid ester
7.0 -2-Hydroxy-4-methoxy-5-sulfoxonium phenone -
7.0 Triethanolamine
0.1 0.1
carboxyvinyl polymer
0.15 0.15 Purified water
Residual Residual -
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−
【0047】<製法>Aのアルコ
ール相をBの水相に添加し、香料を可溶化して美容液を
得た。
■外観状態
配合例1は、無色透明で粘性のある良好な美容液が得ら
れたのに対し、対照例では、黄味が強く粘性のない状態
であった。
■日焼け止め効果
海浜での実使用テストにおいて、2つのサンプルをパネ
ル10名の体半分ずつ塗布仕分け、日焼け具合のアンケ
ート調査及び皮膚トラブルの調査を行なった。その結果
を表2に示す。<Production method> The alcohol phase of A was added to the aqueous phase of B to solubilize the perfume to obtain a beauty serum. (2) Appearance Condition In Formulation Example 1, a colorless, transparent, and viscous beauty serum was obtained, whereas in the control example, the serum had a strong yellowish tinge and no viscosity. ■Sunscreen effect In an actual use test at the beach, two samples were applied to each half of a panel of 10 people, and a questionnaire survey on the degree of sunburn and a survey on skin problems were conducted. The results are shown in Table 2.
【0048】[0048]
【表2】
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−
配合例1の 対照
例1の
サンプル塗布部 サンプル塗布部−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−− パネルA
○ △
B ○
△
C △
×
D ○
× E
△
△ F
△
× G
○
× H
○
△ I
○
△ J
○
△−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−皮膚トラブル件数
なし
ひりつき2件
かゆみ 5件
発疹 3件−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−日焼けの程
度の評価基準
強い紅班が認められた … ×僅かに紅班が認
められた … △
紅班は認められなかった … ○[Table 2] −−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−
Formulation example 1 Control example 1
Sample application section Sample application section------
−−−−−−−−−−−−−−−−−−−−−−−−−
-------- Panel A
○ △
B ○
△
C △
×
D ○
×E
△
△F
△
× G
○
×H
○
△ I
○
△J
○
△−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−Number of skin problems None
2 cases of irritation
Itching 5 cases
3 cases of rash----------------------
−−−−−−−−−−−−−−−−−−−−Evaluation criteria for degree of sunburn Strong erythema was observed … × Slight erythema was observed … △ Erythema was not observed There wasn’t… ○
【0049】これらの結果より糖桂皮酸誘導体を配合し
た皮膚外用剤は、従来の水溶性紫外線吸収剤を配合した
皮膚外用剤より紫外線防御効果が高く、皮膚トラブルの
ない安全性が高いものであった。[0049] From these results, it was concluded that external skin preparations containing glycocinnamic acid derivatives have a higher UV protection effect than conventional skin preparations containing water-soluble ultraviolet absorbers, and are highly safe with no skin troubles. Ta.
【0050】以下に本発明にかかる糖桂皮酸誘導体を含
む組成物の配合例を説明する。なお、各皮膚外用剤とも
優れた紫外線防御効果を示した。Examples of formulations of compositions containing sugar cinnamic acid derivatives according to the present invention will be explained below. In addition, each of the skin external preparations showed excellent UV protection effects.
【0051】
配合例2 クリーム
A.油相
ステアリン酸
10.0% ス
テアリルアルコール
4.0 ステアリン酸モノ
グリセリンエステル 8.
0 ビタミンEアセテート
0.5 香料
0.4 エチル
パラベン
0.1 ブチルパラベン
0.1 プロピルパラベン
0.1B.水相
プロピレングリコール
8.0 グリセリン
2.0 マルチトールト
リメトキシ桂皮酸エステル 5.0
水酸化カリウム
0.4 エデ
ト酸三ナトリウム
0.05 精製水
残 余<製法>Aの油相部
とBの水相部をそれぞれ70℃に加熱し完全溶解する。
A相をB相に加えて、乳化機で乳化する。乳化物を熱交
換機を用いて冷却してクリームを得た。Formulation Example 2 Cream A. Oil phase stearic acid
10.0% stearyl alcohol
4.0 Stearic acid monoglycerol ester 8.
0 Vitamin E acetate
0.5 fragrance
0.4 Ethylparaben
0.1 Butylparaben
0.1 Propylparaben
0.1B. Aqueous phase Propylene glycol
8.0 Glycerin
2.0 Maltitol trimethoxy cinnamic acid ester 5.0
potassium hydroxide
0.4 Trisodium edetate
0.05 Purified water
Remains <Production method> The oil phase part of A and the aqueous phase part of B are heated to 70°C and completely dissolved. Add phase A to phase B and emulsify with an emulsifier. The emulsion was cooled using a heat exchanger to obtain cream.
【0052】
配合例3 クリーム
A.油相
セタノール
4.0
ワセリン
7.0 イ
ソプロピルミリステート
8.0 スクワラン
12.0 ジメチルポリシロキサン
3
.0 ステアリン酸モノグリセリンエステル
2.2 POE(20)ソルビ
タンモノステアレート
2.8 グリチルレチン酸ステアレートBHT
0.02 エチルパラベン
0.1 ブチルパラベン
0.1B.水相
1.3ブチレングリコール
7.0 エデト酸二ナト
リウム
0.07 フェノキシエタノール
0.2 L−アスコルビン酸リン酸エステルマグネシ
ウム塩 3.0 ポリアクリル酸アルキルエステル
1.0 ソル
ビトールトリメトキシ桂皮酸エステル
7.0 精製水
残 余<製法>配合例2に準じてクリームを得た
。Formulation Example 3 Cream A. Oil phase Setanol
4.0
Vaseline
7.0 Isopropyl myristate
8.0 Squalane
12.0 Dimethylpolysiloxane
3
.. 0 Stearic acid monoglycerin ester
2.2 POE (20) Sorbitan Monostearate
2.8 Glycyrrhetinic acid stearate BHT
0.02 Ethylparaben
0.1 Butylparaben
0.1B. Water phase 1.3 butylene glycol
7.0 Edetate disodium
0.07 Phenoxyethanol
0.2 L-ascorbic acid phosphate ester magnesium salt 3.0 Polyacrylic acid alkyl ester 1.0 Sorbitol trimethoxy cinnamate ester
7.0 Purified water
Residue <Production method> A cream was obtained according to Formulation Example 2.
【0053】
配合例4 乳液
A.油相
スクワラン
5.0
オレイルオレート
3.0 ワセリン
2.0 ソルビタンセ
スキオレイン酸エステル
0.8 ポリオキシエチレンオレイルエーテル(20
E.O.) 1.2 2−エチルヘキシル−p−メ
トキシシンナメート 3.0 メチルパラベン
0.15 香料
0.12B.水相
ジプロピレングリコール
5.0 エタノール
3.0 カルボキシビニル
ポリマー
0.17 ヒアルロン酸ナトリウム
0.1
マルチトールトリメトキシ桂皮酸エステル
4.0 水酸化カリウム
0.08 ヘキサメタリン酸ナトリウム
0.05 精製
水
残 余<製法
>配合例2に準じて乳液を得た。Formulation Example 4 Emulsion A. Oil phase squalane
5.0
oleyl oleate
3.0 Vaseline
2.0 Sorbitan sesquioleate ester
0.8 Polyoxyethylene oleyl ether (20
E. O. ) 1.2 2-ethylhexyl-p-methoxycinnamate 3.0 Methylparaben
0.15 fragrance
0.12B. Aqueous phase dipropylene glycol
5.0 Ethanol
3.0 Carboxyvinyl polymer
0.17 Sodium hyaluronate
0.1
Maltitol trimethoxy cinnamic acid ester
4.0 Potassium hydroxide
0.08 Sodium hexametaphosphate
0.05 Purified water
Residue <Manufacturing method> A milky lotion was obtained according to Formulation Example 2.
【0054】
配合例5 クリーム
A.油相
ベヘニルアルコール
0.5% 12−
ヒドロキシステアリン酸コレスタノールエステル 2.
0 スクワラン
7.0
ホホバオイル
5.0 自己
乳化型モノステアリン酸グリセリン
2.5 ポリオキシエチレンソルビタン
モノステアリン酸エステル(20EO)
1.5 2−ヒドロキシ
−4−メトキシベンゾフェノン 3.0
エチルパラベン
0.2 ブチルパ
ラベン
0.1 香料
0.1B.水相
プロピレングリコール
5.0 グリセリン
5.0 ビーガム(モン
モリロナイト)
3.0 水酸化カリウム
0.
3 マルチトールトリメトキシ桂皮酸エステル
6.0 エデト酸三ナトリウム
0.08<製法>配合例2に準じクリームを得た。Formulation Example 5 Cream A. Oil phase behenyl alcohol
0.5% 12-
Hydroxystearic acid cholestanol ester 2.
0 squalane
7.0
jojoba oil
5.0 Self-emulsifying glyceryl monostearate
2.5 Polyoxyethylene sorbitan monostearate (20EO)
1.5 2-hydroxy-4-methoxybenzophenone 3.0
ethylparaben
0.2 Butylparaben
0.1 Fragrance
0.1B. Aqueous phase Propylene glycol
5.0 Glycerin
5.0 Veegum (montmorillonite)
3.0 Potassium hydroxide
0.
3 Maltitol trimethoxy cinnamate ester
6.0 Trisodium edetate
0.08 <Production method> A cream was obtained according to Formulation Example 2.
【0055】
配合例6 粉末入り化粧水
A.油相
エタノール
8.0
POE(60)グリセリルモノイソステアレート
2.0 L−メントール
0.1
カンファー
0.1
メチルパラベン
0.1 香料
0.03B.水相
グリセリン
3.5
ソルビトールトリメトキシ桂皮酸エステル
4.0 亜鉛
1.5 カオリン
0.5 ベントナイト
0.3 ヘキサメタリン酸ナトリウム
0.03 精製水
残 余<製法>
配合例1に準じた製法で粉末入り化粧水を得た。Formulation Example 6 Powdered lotion A. Oil phase ethanol
8.0
POE (60) glyceryl monoisostearate
2.0 L-menthol
0.1
camphor
0.1
Methylparaben
0.1 Fragrance
0.03B. Aqueous phase glycerin
3.5
Sorbitol trimethoxy cinnamate ester
4.0 Zinc
1.5 Kaolin
0.5 bentonite
0.3 Sodium hexametaphosphate
0.03 Purified water
Residue <Production method>
A powdered lotion was obtained using a manufacturing method similar to Formulation Example 1.
【図1】本発明にかかるマルチトールトリメトキシ桂皮
酸エステルの赤外吸収スペクトル図である。FIG. 1 is an infrared absorption spectrum diagram of maltitol trimethoxy cinnamic acid ester according to the present invention.
【図2】本発明にかかるマルチトールトリメトキシ桂皮
酸エステルの13C−NMR図である。FIG. 2 is a 13C-NMR diagram of maltitol trimethoxy cinnamic acid ester according to the present invention.
【図3】本発明にかかるマルチトールトリメトキシ桂皮
酸エステルの1H−NMR図である。FIG. 3 is a 1H-NMR diagram of maltitol trimethoxy cinnamic acid ester according to the present invention.
【図4】本発明にかかるマルチトールトリメトキシ桂皮
酸エステルの紫外線吸収スペクトル図である。FIG. 4 is an ultraviolet absorption spectrum diagram of maltitol trimethoxy cinnamic acid ester according to the present invention.
【図5】本発明にかかるソルビトールトリメトキシ桂皮
酸エステルの赤外吸収スペクトル図である。FIG. 5 is an infrared absorption spectrum diagram of sorbitol trimethoxycinnamate according to the present invention.
【図6】本発明にかかるルビトールトリメトキシ桂皮酸
エステルの13C−NMR図である。FIG. 6 is a 13C-NMR diagram of rubitol trimethoxy cinnamic acid ester according to the present invention.
【図7】本発明にかかるソルビトールトリメトキシ桂皮
酸エステルの1H−NMR図、FIG. 7: 1H-NMR diagram of sorbitol trimethoxy cinnamic acid ester according to the present invention,
【図8】本発明にかかるソルビトールトリメトキシ桂皮
酸エステルの紫外線吸収スペクトル図である。FIG. 8 is an ultraviolet absorption spectrum diagram of sorbitol trimethoxycinnamate according to the present invention.
Claims (2)
誘導体。 【化1】 (式中Aは糖又は糖アルコールからn個の水酸基を除い
た残基、Xはアルコキシ基、aは1〜3の整数、nは整
数)[Claim 1] A sugar cinnamic acid derivative represented by the following general formula 1. [Chemical formula 1] (In the formula, A is a residue obtained by removing n hydroxyl groups from a sugar or sugar alcohol, X is an alkoxy group, a is an integer from 1 to 3, and n is an integer)
る紫外線吸収剤。2. A UV absorber comprising the sugar cinnamic acid derivative according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2416550A JP3007171B2 (en) | 1990-12-30 | 1990-12-30 | Sugar-cinnamic acid derivatives and UV absorbers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2416550A JP3007171B2 (en) | 1990-12-30 | 1990-12-30 | Sugar-cinnamic acid derivatives and UV absorbers |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04305592A true JPH04305592A (en) | 1992-10-28 |
JP3007171B2 JP3007171B2 (en) | 2000-02-07 |
Family
ID=18524770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2416550A Expired - Fee Related JP3007171B2 (en) | 1990-12-30 | 1990-12-30 | Sugar-cinnamic acid derivatives and UV absorbers |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3007171B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363195A (en) * | 2001-06-01 | 2002-12-18 | Yoshitomi Fine Chemicals Ltd | Derivative of cinnamic acid amide, method for producing the same and water soluble ultraviolet absorber |
WO2006047466A2 (en) * | 2004-10-21 | 2006-05-04 | Duke University | Ophthamological drugs |
JP2006131855A (en) * | 2004-11-05 | 2006-05-25 | Shiseido Co Ltd | Water-soluble ultraviolet absorber and ultraviolet-ray absorbing composition containing the same, skin external preparation |
JP2010037513A (en) * | 2008-08-08 | 2010-02-18 | Konica Minolta Opto Inc | Optical film, production method of optical film, polarizing plate and liquid crystal display |
CN102659956A (en) * | 2012-04-26 | 2012-09-12 | 江南大学 | Modified ultraviolet absorbing agent based on araboxylan and preparation method thereof |
-
1990
- 1990-12-30 JP JP2416550A patent/JP3007171B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002363195A (en) * | 2001-06-01 | 2002-12-18 | Yoshitomi Fine Chemicals Ltd | Derivative of cinnamic acid amide, method for producing the same and water soluble ultraviolet absorber |
WO2006047466A2 (en) * | 2004-10-21 | 2006-05-04 | Duke University | Ophthamological drugs |
WO2006047466A3 (en) * | 2004-10-21 | 2006-09-21 | Univ Duke | Ophthamological drugs |
JP2006131855A (en) * | 2004-11-05 | 2006-05-25 | Shiseido Co Ltd | Water-soluble ultraviolet absorber and ultraviolet-ray absorbing composition containing the same, skin external preparation |
JP2010037513A (en) * | 2008-08-08 | 2010-02-18 | Konica Minolta Opto Inc | Optical film, production method of optical film, polarizing plate and liquid crystal display |
CN102659956A (en) * | 2012-04-26 | 2012-09-12 | 江南大学 | Modified ultraviolet absorbing agent based on araboxylan and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP3007171B2 (en) | 2000-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4584190A (en) | Novel chalcone derivatives and ultraviolet absorbers comprising the same | |
US5426210A (en) | Adduct of cinnamic acid and glycerin, ultraviolet absorbent and external preparation for skin | |
JP2003524648A (en) | Formulations for protection against oxidative stress containing benzofuranone derivatives | |
KR100226142B1 (en) | Benzophenone derivative, ultraviolet absorbent and external preparation for skin | |
JP3007171B2 (en) | Sugar-cinnamic acid derivatives and UV absorbers | |
JP3034057B2 (en) | Sugar-cinnamic acid derivatives and UV absorbers | |
EP0649648B1 (en) | Skin whitening agents containing glycosides | |
JP2999829B2 (en) | External preparation for skin | |
JP2999564B2 (en) | External preparation for skin | |
DE10025558A1 (en) | Topical composition containing at least one aryloxime and process for its preparation | |
JPH0580449B2 (en) | ||
JP3140575B2 (en) | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same | |
JP3207471B2 (en) | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same | |
JP3144715B2 (en) | Styryl ketone derivative, ultraviolet absorber using the same, and external preparation for skin containing the same | |
JP4422329B2 (en) | Benzo [B] pyran derivatives useful as external preparations for skin | |
JP2923358B2 (en) | Glycerin cinnamate adduct, UV absorber and external preparation for skin | |
JP2962366B2 (en) | External preparation for skin | |
JPH08283286A (en) | Benzophenone derivative, ultraviolet light absorber and dermal preparation for external use blended with the same | |
JP3534939B2 (en) | Cinnamic acid derivatives, UV absorbers and skin external preparations | |
JPH07242693A (en) | 1,3-propanedione derivative, ultraviolet light absorber and skin external preparation containing the same blended therein | |
JPH08127589A (en) | Glucohydantoin derivative, ultraviolet absorbent and skin preparation for external use | |
JPH05186429A (en) | Benzylidenehydantoin derivative and skin external preparation blended with the same | |
JPH09268194A (en) | Cinnamic acid derivative, ultraviolet absorber and preparation for external use for skin | |
JPH09255696A (en) | Benzophenone derivative, ultraviolet light absorbent and preparation containing the same and used for external use for skin | |
JPH07330680A (en) | Poly(alkyleneoxy) group-bearing benzal malonate derivative, production thereof and uv rays absorber and cosmetic containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19991109 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071126 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081126 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |